EP1066404A4 - Verfahren zur herstellung von bibliotheken von exprimierbaren gensequenzen - Google Patents

Verfahren zur herstellung von bibliotheken von exprimierbaren gensequenzen

Info

Publication number
EP1066404A4
EP1066404A4 EP99917335A EP99917335A EP1066404A4 EP 1066404 A4 EP1066404 A4 EP 1066404A4 EP 99917335 A EP99917335 A EP 99917335A EP 99917335 A EP99917335 A EP 99917335A EP 1066404 A4 EP1066404 A4 EP 1066404A4
Authority
EP
European Patent Office
Prior art keywords
methods
gene sequences
expressible gene
producing libraries
libraries
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99917335A
Other languages
English (en)
French (fr)
Other versions
EP1066404A1 (de
Inventor
Joseph Manuel Fernandez
John Alastair Heyman
James Paul Hoeffler
Heather Lynn Marks-Hull
Michelle Lynn Sindici
Wai-Yee Lee
Luis Foncerrada
Robert Marcil
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Life Technologies Corp
Original Assignee
Invitrogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Invitrogen Corp filed Critical Invitrogen Corp
Publication of EP1066404A1 publication Critical patent/EP1066404A1/de
Publication of EP1066404A4 publication Critical patent/EP1066404A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
EP99917335A 1998-04-03 1999-04-02 Verfahren zur herstellung von bibliotheken von exprimierbaren gensequenzen Withdrawn EP1066404A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5493698A 1998-04-03 1998-04-03
PCT/US1999/007270 WO1999051766A1 (en) 1998-04-03 1999-04-02 Methods for producing libraries of expressible gene sequences
US54936 2002-01-25

Publications (2)

Publication Number Publication Date
EP1066404A1 EP1066404A1 (de) 2001-01-10
EP1066404A4 true EP1066404A4 (de) 2004-04-07

Family

ID=21994497

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99917335A Withdrawn EP1066404A4 (de) 1998-04-03 1999-04-02 Verfahren zur herstellung von bibliotheken von exprimierbaren gensequenzen

Country Status (5)

Country Link
EP (1) EP1066404A4 (de)
JP (1) JP2002510502A (de)
AU (1) AU754276B2 (de)
CA (1) CA2324514A1 (de)
WO (1) WO1999051766A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6870046B2 (en) * 2001-04-26 2005-03-22 Isis Pharmaceuticals, Inc. Antisense modulation of interferon gamma receptor 2 expression
ZA200305980B (en) 2001-02-12 2007-01-31 Res Dev Foundation Modified proteins, designer toxins, and methods of making thereof
US7101977B2 (en) 2001-07-17 2006-09-05 Research Development Foundation Therapeutic agents comprising pro-apoptotic proteins
WO2024192291A1 (en) 2023-03-15 2024-09-19 Renagade Therapeutics Management Inc. Delivery of gene editing systems and methods of use thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996019497A1 (en) * 1994-12-19 1996-06-27 Sloan-Kettering Institute For Cancer Research Method for molecular cloning and polynucleotide synthesis using vaccinia dna topoisomerase
WO1996034112A1 (en) * 1995-04-24 1996-10-31 Chromaxome Corp. Methods for generating and screening novel metabolic pathways
WO1996039186A1 (en) * 1995-06-06 1996-12-12 Cedars-Sinai Medical Center Anti-neutrophil cytoplasmic antibody material associated with ulcerative colitis and related methods and kits
WO1999051620A1 (en) * 1998-04-03 1999-10-14 Invitrogen Corporation Libraries of expressible gene sequences

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU582288B2 (en) * 1986-03-07 1989-03-16 Damon Biotech Inc. Vector and method for achieving high level expression in eukaryotic cells
US5723286A (en) * 1990-06-20 1998-03-03 Affymax Technologies N.V. Peptide library and screening systems

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996019497A1 (en) * 1994-12-19 1996-06-27 Sloan-Kettering Institute For Cancer Research Method for molecular cloning and polynucleotide synthesis using vaccinia dna topoisomerase
WO1996034112A1 (en) * 1995-04-24 1996-10-31 Chromaxome Corp. Methods for generating and screening novel metabolic pathways
WO1996039186A1 (en) * 1995-06-06 1996-12-12 Cedars-Sinai Medical Center Anti-neutrophil cytoplasmic antibody material associated with ulcerative colitis and related methods and kits
WO1999051620A1 (en) * 1998-04-03 1999-10-14 Invitrogen Corporation Libraries of expressible gene sequences

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9951766A1 *

Also Published As

Publication number Publication date
WO1999051766A1 (en) 1999-10-14
EP1066404A1 (de) 2001-01-10
JP2002510502A (ja) 2002-04-09
AU3548299A (en) 1999-10-25
AU754276B2 (en) 2002-11-07
CA2324514A1 (en) 1999-10-14

Similar Documents

Publication Publication Date Title
AU2792499A (en) Improved methods for synthesis of oligonucleotides
AU2001288257A1 (en) Improved methods of gene silencing using inverted repeat sequences
HUP0103571A3 (en) Characterisation of gene function using double stranded rna inhibition
EP1114148A4 (de) System zur schnellen manipulation von nukleinsäuresequenzen.
HUP0004115A2 (en) Novel nucleotide sequences coding for the pck gene
AU3653399A (en) Method of isolating target specific oligonucleotide ligands
HUP0103214A3 (en) Method of dna vaccination
AU2851699A (en) Method of producing ceramic foams
IL141660A0 (en) Sequences characteristic of hypoxia-regulated gene transcription
EP1066309A4 (de) Bibliotheken exprimierbarer gensequenzen
IL145221A0 (en) Multiple component rna vector system for expression of foreign sequences
AU4655599A (en) Method of preparing objects containing dna
EP1581614A3 (de) Nukleotidsequenzen zur genregulierung und verfahren zu deren verwendung
AU5328600A (en) Nucleotide sequences for gene regulation and methods of use thereof
EP1066404A4 (de) Verfahren zur herstellung von bibliotheken von exprimierbaren gensequenzen
EP1034308A4 (de) Verfahren zur herstellung conditionell exprimierten mutanten zellen mit hilfe von expriemirten antisense sequenzen
HUP0104519A3 (en) Methods of indentifying antigen gene sequences
AU1975000A (en) Method for constructing libraries of phenotypic profiles
AU2001245547A1 (en) Process for producing peptide sequences possessing anti-hypertension activity
AU2002219856A1 (en) Method for screening of dna libraries and generation of recombinant dna constructs
AU2003200403A1 (en) Methods for Producing Libraries of Expressible Gene Sequences
HUP0202315A2 (en) Process for deacylation of lipodepsipeptides
AU8658798A (en) Procedure for preparing enriched gene expression libraries
AU3807299A (en) Methods for quantitating low level modifications of nucleotide sequences
AU2001264845A1 (en) Nucleotide sequences encoding ramosa 1 gene and methods of use for same

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20001031

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): CH DE FR GB LI NL

RBV Designated contracting states (corrected)

Designated state(s): CH DE FR GB LI NL

RIN1 Information on inventor provided before grant (corrected)

Inventor name: MARCIL, ROBERT

Inventor name: FONCERRADA, LUIS

Inventor name: LEE, WAI-YEE

Inventor name: SINDICI, MICHELLE, LYNN

Inventor name: MARKS-HULL, HEATHER, LYNN

Inventor name: HOEFFLER, JAMES, PAUL

Inventor name: HEYMAN, JOHN, ALASTAIR

Inventor name: FERNANDEZ, JOSEPH, MANUEL

A4 Supplementary search report drawn up and despatched

Effective date: 20040220

RIC1 Information provided on ipc code assigned before grant

Ipc: 7G 01N 33/68 B

Ipc: 7C 12N 15/10 B

Ipc: 7G 01N 33/53 B

Ipc: 7C 12Q 1/06 A

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20041209